Investing In Marijuana Earnings Growth
Long/Short Equity, Special Situations, Growth, Growth At A Reasonable Price
Seeking Alpha Analyst Since 2007
He founded Invest2Success.com to empower independent and institutional investors traders to take control of their financial destiny by providing them education training mentorship and support for them to research analyze invest and trade in the markets successfully in the long-term.
As he says, "With knowledge, dated goals, a plan of action, then taking action, profitable investing and trading success will only be a matter of time."
Getting High On Pot Stocks by Zacks Investment Research
Are you stressed out and need a release? Boss got you singing the blues? Well if you are in Colorado, you roll a fat one and as the kids say "chillax."
I am not sure what "chillax" means, but it appears to be a combination of chill out and relax. Seems to me they want to do the same thing twice as hard, which just gives me faith in our collective futures.
With all the stories of legalized weed, I decided to take a look at this topic a little more closely. I first took a look at http://www.marijuana.com/ to learn about this green plant and what it can do. Then I saw some tweets about something call "kush" selling for $400 an ounce and I nearly fell back into the couch and dreamed of easy money.
I mean, $400 an ounce, 16 ounces in a pound, it sounds like I don't need to dream of being Walter White anymore... more like Fritz Haber.
The Green Rush
The gold rush sent tons of people west with the promise of riches hoping that they would "pan out." Today, a similar rush, just of the green variety has people moving west looking to "pot out."
But there are some road blocks in place that are preventing us regular people from just setting up shop in CO or WA. Maybe it would just be easier to buy stock in a company that is already doing that! DUDE!
Recently I have been watching Growlife and how it has gotten so high lately. Then I saw that it's a penny stock, and doesn't have a Zacks Rank, so I cannot pass this joint to the left hand side.
Medbox (MDBX) is another player in this green space. They have a little different take on the business as they have a machine that dispenses medication to individuals based on biometric identification (fingerprints).
Dude! What a great idea! I mean I don't even have to converse with another human when I am going to get my fix! But seriously, the firm is just selling the machines and not the green, so this is an example of buying the bullet makers and not the army in time of war.
MDBX does not have a Zacks Rank either. I am seeing a trend here.
I Could Ramble On and On and On
I kept looking for a stock that fits this new green space. But the more I looked, the more I found penny stocks that have ripped higher. None of which had a Zacks Rank.
What does that mean for me? Well that means I cannot recommend a good pot stock. I can only sit back and watch as these stocks fire up as the green rush gets underway. What will change my mind and get on bong... I mean on board, is if some analysts pick up coverage of the sector. Then, with earnings estimates, the stock would become eligible for a Zacks Rank.
Conclusion
Pot stocks are hot, but investors may get burned if they are not careful. The Zacks Rank will help you find the stocks that are seeing earnings estimate revisions, and that insight can help you stick with a higher flyer and prevent you from coming down from a big high too. As much as I want to recommend one or more of these stocks, I cannot, but if there are any analysts willing to do a deep dive into the jungle of pot stocks, I am sure you will have an instant following!
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.